Live Breaking News & Updates on Annabinoid therapy

GCANRx Announces Completion of Preclinical Study for

BALTIMORE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company.

Jerusalem , Israel-general- , Israel , Hebrew-university , Yerushalayim , Boston , Massachusetts , United-states , Adi-aran , Aitan-zacharin , Intel , Google